Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
Saudi J Kidney Dis Transpl. 2023 Jul 1;34(4):279-287. doi: 10.4103/1319-2442.395443. Epub 2024 Feb 12.ABSTRACTHyperuricemia is a risk factor for the progression of chronic kidney disease (CKD). We compared febuxostat versus allopurinol in the progression of CKD and hyperuricemia in 101 patients with Stage 3-4 CKD treated with febuxostat or allopurinol for at least 6 months for hyperuricemia (>7 mg/dL) between January 2012 and December 2016. Baseline characteristics, serum uric acid (SUA), serum creatinine, and estimated glomerular filtration rate (eGFR) at entry and 6 months were compared. The primary outcome was the de...
Source: Saudi Journal of Kidney Diseases and Transplantation - February 12, 2024 Category: Urology & Nephrology Authors: Shankar Prasad Nagaraju Srinivas Vinayak Shenoy Indu Rao Ravindra Attur Prabhu Dharshan Rangaswamy Mohan V Bhojaraja Vasudeva Guddattu Source Type: research
